Straits Times Index
3,174.68 -12.98 (-0.41%) Nikkei
37,136.11 -943.59 (-2.48%) Hang Seng
16,184.29 -201.58 (-1.23%) FTSE 100
7,877.05 +29.06 (+0.37%) Bitcoin USD
61,955.71 +255.07 (+0.41%) CMC Crypto 200
1,280.11 +394.57 (+43.04%)
Almaden Minerals Ltd. (AMM.TO)
| Previous close | 0.1700 |
| Open | 0.1700 |
| Bid | 0.1700 x 0 |
| Ask | 0.1750 x 0 |
| Day's range | 0.1700 - 0.1700 |
| 52-week range | 0.1400 - 0.2200 |
| Volume | |
| Avg. volume | 30,422 |
| Market cap | 23.328M |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0900 |
| Earnings date | 08 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireAlmaden Provides Corporate Update
VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) is providing an update regarding its Request for Consultations delivered to the United Mexican States (“Mexico”, see press release dated December 14, 2023), and its listing on the NYSE American stock exchange (see press release of October 25, 2023). Request for Consultations As previously reported, on December 13, 2023, Almaden delivered to Mexico a wri
- GlobeNewswire
Almaden requests consultations with Mexico under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership
VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) announces that it has delivered to the United Mexican States (“Mexico”) a Request for Consultations in accordance with the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) relating to an investment dispute with Mexico. Almaden sent the Request for Consultations to Mexico’s General Directorate of Legal Consultancy for Intern
- GlobeNewswire
Almaden Announces Extension of Cure Period for NYSE American Listing
VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) announces that, further to its press release of April 21, 2023, it has received an extension of its cure deadline from October 19, 2023 to April 19, 2024 (“New Cure Deadline”). As previously announced, Almaden is not in compliance with the continued listing standards of the NYSE American exchange because the Company’s securities have been selling for a l
